C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/00 (2006.01) A61K 31/33 (2006.01) A61K 31/395 (2006.01) A61K 31/415 (2006.01) A61K 31/55 (2006.01) A61K 31/675 (2006.01) C07D 223/16 (2006.01) C07D 235/14 (2006.01) C07D 235/16 (2006.01) C07D 243/14 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01) C07D 487/04 (2006.01) C07D 491/04 (2006.01) C07D 491/056 (2006.01) C07D 49
Patent
CA 2193966
Compounds are disclosed which are vitronectin receptor antagonists useful in the treatment of osteoporosis. These compounds comprise a fibrinogen receptor antagonist template linked to a heterocyclic moiety.
L'invention concerne des composés constituant des antagonistes du récepteur de la vitronectine qui sont utiles dans le traitement de l'ostéoporose. Ces composés comprennent une matrice antagoniste de récepteur fibrinogène liée à une fraction hétérocyclique.
Ali Fadia El-Fehail
Bondinell William
Huffman William Francis
Keenan Richard Mcculloch
Kwon Chet
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Vitronectin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitronectin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitronectin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1480546